It is important that the biopharmaceutical industry strive for the highest standards in order to restore its reputation with patients, physicians and payers. Unfortunately, Novartis’s recent actions with Essential Consultants is a big step backward.
It is important that the biopharmaceutical industry strive for the highest standards in order to restore its reputation with patients, physicians and payers. Unfortunately, Novartis’s recent actions with Essential Consultants is a big step backward.